The Asia-Pacific ophthalmic diagnostic devices market size was valued at $1,553.80 million in 2019 and is projected to reach $2,182.83 million by 2027, registering a CAGR of 4.3% from 2019 to 2027.
An ophthalmologist can perform ophthalmic exam which is a comprehensive series of tests. These tests check both vision and the health of the patient’s eyes. The tools used by Optometrists are painless, effective, and extremely accurate in diagnosing the eye’s health status. The standard eye exam tools used by both optometrists and ophthalmologists during their examinations are tonometer, phoropter, retinoscope, autorefractor, retinal camera, ophthalmoscope, and others. The following test can be performed by diagnostic tools such as slit lamp test, visual acuity and refraction, pupil dilation, and others. Furthermore, imaging technologies in all fields of ophthalmology boosts the diagnostic capabilities. Recent advancements in these technologies help enhance the effect on retinal imaging during diagnosis. For instance, quantitative evaluation of the structure and function of the optic nerve is vital to diagnose glaucoma, where optical coherence tomography (OCT), fundus autofluorescence (FAF), and fluorescein angiography helps ophthalmologist to diagnose the condition.
The growth of the Asia-Pacific ophthalmic diagnostic devices market is majorly driven by aging population, increase in prevalence of ophthalmic diseases such as cataract and glaucoma, technological advancements in handheld devices for detecting glaucoma and macular degeneration, and increase in R&D activities. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. On the contrary, the countries such as China, India, and other Asia-Pacific countries possess high growth potential, owing to improving healthcare infrastructures in these countries.
The emergence of the novel coronavirus SARS-CoV-2, and the resulting disease COVID-19, has created a major international public health challenge. This has impacted all the sectors, disrupting the supply chain, and creating a shortage of supplies. As the government has imposed lockdown, the ophthalmology diagnostics clinics and the surgeries are postponed. This is due to the ophthalmologists are at high risk, considering the proximity to patients when inspecting patients and transmission may happen, including the eyes. Furthermore, the government has imposed guidelines for practice such as the use of teleophthalmology services for the patients who require urgent follow-up.
The Asia-Pacific ophthalmic diagnostic devices market is segmented on the basis of product and country. By product, the market is bifurcated into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer. The fundus camera segment is further classified into mydriatic fundus cameras, non-mydriatic fundus cameras, hybrid fundus cameras, and ROP fundus cameras. The mydriatic fundus cameras further divided into tabletop and handheld. the non-mydriatic fundus cameras further divided into tabletop and handheld. the perimeters segment is further classified into static, kinetic, and combination. The static segment is further divided into handheld perimeter and desktop perimeter. The kinetic segment is further divided into handheld perimeter and desktop perimeter. The combination segment is further divided into handheld perimeter and desktop perimeter. Country wise, it is analyzed across Japan, China, Australia, India, South Korea, Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, and Rest of Asia-Pacific.
Product segment review
By product, the optical coherence tomography (OCT) systems segment accounted for the largest market share in 2019, and is expected to maintain its dominance during the forecast period, owing to the fact that the OCT device enables ophthalmologists to accurately map and measure the distinctive layers of the retina. Moreover, the major applications of the device include macula imaging, optic nerve & retinal nerve fiber layer (RNFL) imaging, and support in analyzing the morphology & quantifying changes in various disease states further boosts the growth of the Asia-Pacific ophthalmic diagnostic devices market.
Optical Coherence Tomography Systems segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Country segment review
Japan accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2019 to 2027, due to high expenditure on R&D, presence of large number of elder population, and rise in eye disorder. However, India is expected to register highest CAGR during the forecast period, as the Governments of the country is investing more in the development of healthcare infrastructure, rising ageing population, and rise in adoption of ophthalmic diagnostic devices for diagnose eye diseases efficiently. In addition, the rise in medical tourism in the country further boosts the growth of the Asia-Pacific ophthalmic diagnostic devices market.
India would exhibit the highest CAGR of 6.7% during 2019-2027.
Some of the key players operating in the Asia-Pacific ophthalmic diagnostic devices market include Carl Zeiss Meditec AG, Halma, plc., Topcon Corporation, Essilor International S.A., Alcon Vision, Nidek Co., Ltd., Haag-Streit Holding AG, Ametek, Inc., Optovue Corporation, and Coburn Technologies, Inc.
Key Benefits For Stakeholders
- This report entails a detailed quantitative analysis along with the current Asia-Pacific ophthalmic diagnostic devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
- The Asia-Pacific ophthalmic diagnostic devices market forecast is studied from 2019 to 2027.
- The Asia-Pacific ophthalmic diagnostic devices market size and estimations are based on a comprehensive analysis of key developments in the Asia-Pacific ophthalmic diagnostic devices industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the Asia-Pacific ophthalmic diagnostic devices market.
Asia-Pacific Ophthalmic Diagnostic Devices Market Report Highlights
Key Market Players
Ametek, Inc., Opotovue Corporation, Topcon Corporation, Carl Zeiss Meditec AG, Halma, plc., Alcon Vision LLC, Nidek Co., Ltd., Haag-Streit Holding AG, Essilor International S.A., Coburn Technologies, Inc.
The Asia-Pacific ophthalmic diagnostic devices market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in prevalence of eye-related diseases in the region.
The Asia-Pacific ophthalmic diagnostic devices market is dominated by well-established players, hence, the market witnesses intense competition. The adoption of these devices has increased considerably, owing to increase in prevalence of eye-related diseases, which propels the market growth. In addition, increase in product launches is expected to contribute toward the growth of the market. As per the analysis in the report, the use of ophthalmic diagnostic devices is highest in Japan, owing to the large of elderly population, development of medical devices in lower cost provides opportunities to the local players, and higher number of product approvals, followed by product launches.